A Lecture by Phil Dell'Orco (Director of Process Engineering, GlaxoSmithKline Pharmaceuticals and Head of Sustainability, GlaxoSmithKline Preclinical Development)
Presented by the Marcel Desautels Institute for Integrated Management
Date: September 7, 2012
Time: 11:00 am - 12:30 pm
Location: Bronfman Building, 2nd Floor Open Area
The sustainability profile of products and processes in chemical and pharmaceutical manufacturing is often something that is measured after the fact rather than designed into the product. As a result, such ‘lagging’ metrics lead to incremental rather than transformational improvement, while tactical and shorter term objectives (such as near-term cost and supply) are achieved. The objective of this interactive presentation will be to illustrate the benefits and challenges of a ‘Green by Design’ (GbD) approach to product development, focusing on pharmaceuticals and fine chemicals. Both scientific innovation and business elements will be emphasized. Through the discussion, participants will gain an improved perspective on the trade-offs involved in a GbD approach, and understand how GbD can be leveraged to drive transformational rather than incremental benefits.
About Phil Dell'Orco:
Phil Dell'Orco is currently Director of Process Engineering, GlaxoSmithKline Pharmaceuticals and Head of Sustainability, GlaxoSmithKline Preclinical Development. Prior to working at GSK and legacy companies, Dr. Dell’Orco worked in an R&D role as a process engineer at Los Alamos National Laboratory within the Explosives Technology and Safety group. He obtained his PhD and MS degrees in Civil Engineering from The University of Texas at Austin, and a B.E. degree in Chemical Engineering from Vanderbilt University.
Event jointly organized with McGill’s Department of Chemistry.
This event is open to the public.
For more details, please contact Adam Halpert at: adam.halpert [at] mcgill.ca.